HOME  >   > 
[] 287ȣ (2017.8.2)
  • ۾
  • ۼ 2017-08-02 14:30:21
  • ȸ 24546
÷ 287.jpg
ѱ̿Ǿǰȸ ׽Ʈ
 
Ϻΰ

Ǿǰ ǥ  Ϻΰ

. Һ ϹǾǰ ǥؼ (62, 1, 2)

. (7, 72, 9)

. Ȱũ Ȯ (9)......

Ϻΰ

Ǿǰ ۿ ر޿ Ǿǰ Ϻΰ

Ǿǰ ۿ ر޿ Կ ־  Ϻ ̺ ϰ, Ǿǰ ۿ ر޿ Ǿǰ 3() ġ ϰ .

. ۿ ر ߰Ͽ Ȯȭ( 21)
. ر Ǿǰ ߰( 3)......

Ϻΰ

դǰ óϺΰ

ݿϿ ա ǰ з οó ϰ  Ÿ Ϻ ̺ ϰ

. աǰ ƴϳ ʰ з Һи ǰ з ż(3, 7)
. ֱ ݿ աǰ з ߰(4)
. ǰȸ ż(14) ......

ǰȸ

̸ ġ ġ () ǰȸ (~8/7)

ֿ䳻
     - Ϲݻ׿
     - ,ȿ ڷ
     - ๰ȣۿ ڷῡ
     - ġ Ȯ ӻ迡
     - 㰡׿


ǰ
- : 2017. 08. 07 ()
- : ÷2.ǰ߼
- : info@kobia.kr

() Ȯ

ǰȸ

躸DZⱸ(WHO) ̿ùз PQ ̵ ǰ (~8/7)

ǰǾǰó 躸DZⱸ(WHO) ̿Ǿǰ ǥȭ о ¼ͷμ ̵ . ϰ , Ǿǰ ̵  

-
. WHO Pilot procedure for prequalification of similar biotherapeutic products.
. WHO Guidelines on submission of documentation for the pilot procedure for prequalification of similar biotherapeutic products approved by stringent regulatory authorties.
. WHO Guidelines on submission of documentation for the pilot procedure for prequalification of similar biotherapeutic products.
. Guidelines on procedures and data requirements for changes to approved biotherapeutic products. 


ǰ
- : 2017. 08. 07 ()
- : 4 / 6
- : info@kobia.kr

̵() Ȯ

ڷ

 Ǿǰ ż 㰡ɻ [ ħ]

Ǿǰ ǰɻ ̵ [ο ȳ]

 
 
 
û ǰ ӻ ܰ
ֽȸ
ڸڸ
20170801 ߵ Ǻο ƮŰ ܵ ECZTRA 2 - ſ ĺ ߵ Ǻο ڿ ƮŰ ܵ ȿ ϴ , ߴ, , 3 ӻ 3 Tralokinumab APFS
()Z Zﺴ 20170731 ȯ̽ ִ PD-L1 ̼ ҼϿ Pembrolizumab ġ 4 ŰƮ
ѱǰֽȸ 20170731 ġ Ұ ༺, ߼ Ǵ ̼ Ǽĵ ӻڿ Ϻ縿+ʸ Ǵ ÷ο+ýöƾ Ϻ縿 ÷ο+ýöƾ 3 ӻ 3 ONO-4538
ѱȭ
()
20170728 ߼ Ǵ ̸ Ŵ B (DLBCL) ڵ鿡 鿪 ۿ, ļ , CD20 /Ǵ ȭп ϴ ƺ縿(MSB0010718C) 1B ٱ ӻ 1b з縿(Utomilumab), ƺ縿(Avelumab)
ѱƽƮī) 20170726 ʴ õȯڸ ߰뷮 뷮 ڸƼڽ׷̵ Ӽ 2-ȿ ߰ Benralizumab (MEDI-563) ȿ ϱ ٱ, , ߴ, ౺, , III ӻ
3 ָ(MEDI-563)
 
 
 
 
FDA  
Drug Name and
FDA Appl. #
Active Ingredients Submission
Classification
Company Approval Date

BENLYSTA
BLA #761043

BELIMUMAB - GLAXOSMITHKLINE LLC 07/20/2017
NITYR
NDA #209449
NITISINONE Ǵ CYCLE PHARMS LTD 07/26/2017
 
EMA  
Name Active Substance Therapeutic areaCompany Date of authorisation/ refusal
Rixathon rituximab Arthritis, Rheumatoid Leukemia,
Lymphocytic, Chronic,
B-Cell Lymphoma,
Non-Hodgkin Microscopic Polyangiitis
Wegener Granulomatosis
15/06/2017

Oxervate

recombinant human Nerve Growth factor (rhNGF) Keratitis 06/07/2017
 
 
 
 
Clinical.gov ̱
NCT
Number
Title Conditions Interventions Sponsor
/Collaborators
Phases
NCT03233724 The Immune Checkpoint Inhibitor Pembrolizumab in Combination With Oral Decitabine and Tetrahydrouridine as First-Line Therapy for Inoperable, Locally Advanced or Metastatic Non-small Cell Lung Cancer

Carcinoma,
Non-Small-Cell Lung
Lung Cancer
Non-Small Cell Lung Cancer

Drug: Decitabine (DAC)
Drug: Tetrahydrouridine (THU)
Drug: Pembrolizumab

National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Phase 1
Phase 2
NCT03233854 CD19/CD22 Chimeric Antigen Receptor T Cells and Chemotherapy in Treating Patients With Recurrent or Refractory CD19 Positive Diffuse Large B-Cell Lymphoma or B Acute Lymphoblastic Leukemia B Acute Lymphoblastic Leukemia
CD19 Positive
Diffuse Large B-Cell Lymphoma
Associated With Chronic Inflammation...
Biological: Chimeric Antigen Receptor T-Cell Therapy
Drug: Cyclophosphamide
Drug: Fludarabine Phosphate
Other: Laboratory Biomarker Analysis
Other: Questionnaire Administration
David Miklos
Stanford University
Phase 2
NCT03233711 Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer Anal Basaloid Carcinoma
Anal Canal Cloacogenic Carcinoma...
Biological: Nivolumab National Cancer Institute (NCI) Phase 2
NCT03232307 Ibrutinib Plus Rituximab and Lenalidomide in Elderly Patients With Newly Diagnosed Mantle Cell Lymphoma (MCL) Hematopoietic/Lymphoid Cancer
Mantle Cell Lymphoma
Drug: Ibrutinib
Drug: Rituximab
Drug: Lenalidomide
Drug: Dexamethasone Sodium Sulfate
M.D. Anderson Cancer Center
Celgene
Janssen Scientific Affairs, LLC
Phase 2
NCT03233347 Doxorubicin Hydrochloride, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma Stage I Hodgkin Lymphoma
Stage IA Hodgkin Lymphoma....
Drug: Brentuximab Vedotin
Drug: Dacarbazine
Drug: Doxorubicin Hydrochloride
Other: Laboratory Biomarker Analysis
Biological: Nivolumab
Drug: Vinblastine
Academic and Community Cancer Research United
National Cancer Institute (NCI)
Phase 2
NCT03233698 Atezolizumab in Treating Patients With Newly Diagnosed and Metastatic Alveolar Soft Part Sarcoma That Cannot Be Removed by Surgery Metastatic Alveolar
Soft Part Sarcoma

Drug: Atezolizumab
Other: Laboratory Biomarker Analysis
Other: Pharmacological Study

National Cancer Institute (NCI)

Phase 2
Clinical.gov
NCT
Number
Title Conditions Interventions Sponsor
/Collaborators
Phases Nation
NCT03232268 HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies Acute Myeloid Leukemia|Myelodysplastic Syndromes Biological: HLA-mismatched microtransplantation Institut Paoli-Calmettes Phase 1
Clinical.gov Ϻ

NCT
Number

Title Conditions Interventions Sponsor
/Collaborators
Phases
NCT03233217 Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients 65 Years Influenza Biological: QIV-HD by IM
Biological: QIV-SD by SC
Biological: QIV-HD by SC
Sanofi Pasteur, a Sanofi Company
Sanofi K.K.|Sanofi
Phase 1
Phase 2
 
 
 
 
 
ѱǻ Ʈʸ ȳ (AusBiotech, Bio-Europe) (Ͻ 8 7() 18:00)

ѱǻ ǻо ȸ Ͽ
Ʈʸ(AusBiotech,BiO-EUROPE​) Ʈʸ 50% ϰ ֽϴ.

AusBiotech BIO-EUROPE 2017

Ͻ: '17.10.25 () ~ 27 (), (3ϰ)

: Adelaide Convention Centre, South Australia

Ϻ: 970,000 (, Ʈʸ, ۷, Ͻ )

Ͻ: '17.11.6 () ~ 8 (), (3ϰ)

: Berlin, Germany

Ϻ: 1,500,000 (, Ʈʸ, ۷, Ͻ )

γ

CPhI & BioPh Korea 2017 ѱ̿Ǿǰ ȸ ȫ ȳ

 ȸ   ȯ ݳ 8 22(ȭ) 3ϰ  ڿ ֵǴ 
̿ ȸ CPhI & BioPh Korea 2017 մϴ.

 

ȸ ۷ι  ϰ ѱ ̿Ǿǰ θ ؿܿ ȫϰ,
ȸ 
ν  ȸ Ұڷ( ν) ġϰ Ͽ
   ȸ    ۺθ Ź 帮ڽϴ.

 ̿ (02-725-8438 / yjlee@kobia.kr)
߼۱: ~8/18ϱ

 
 

     





286ȣ (2017.7.25)
Vol. 61 (August 7, 2017)

Wonderful archive of porn tapes on https://pornsok.com Даркнет магазин Blacksprut Free ebooks Library zlib project z-library Z-Library project Комиксы, Манга читать онлайн на Русском языке Immediate Affinity

Discover the real world of gambling for Korean players at bons casino, a licensed online casino! Hundreds of exciting games for every taste are waiting for you. From classic slots with reels to games with live dealers. BONS Casino offers registration bonuses, free spins, deposit extra funds for games with live dealers, and other promotions! Play and score at BONS CASINO now!